Have the Blockbuster Diabetes Drug Trials Been Biased? Have the Blockbuster Diabetes Drug Trials Been Biased?
A recent article from Japan is the latest to point out imbalances in the study arms of the FDA-mandated cardiovascular outcomes trials of newer type 2 diabetes medications.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Japan Health | Primary Care | Study